Aurobindo Pharma Ltd has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Quinapril tablets.
Quinapril tablets is the generic equivalent of Pfizer Pharmaceuticals Ltd’s Accupril tablets and are indicated for the treatment of hypertension, the Hyderabad-based company said in a release.
The market size of the product was estimated to be $49 million for the 12 months ending September 2012, according to IMS.
The product was approved out of the Unit VII (SEZ) formulations facility in Hyderabad.